Chronic PTSD is a systemic disorder with high allostatic load, shaped by advances in genetics, neurobiology, and brain imaging. Current evidence-based treatments include pharmacological and psychotherapeutic approaches, but outcomes are often suboptimal due to barriers such as comorbidity, emotional dysregulation, suicidality, dissociation, substance use, and trauma-related guilt and shame. These challenges drive emerging novel approaches: early interventions during the Golden Hours, medication augmentation, psychedelics, and brain- and nervous-system-targeted interventions. A phase-oriented treatment framework is recognized to align interventions with the disorder's pathophysiology. Revisions to guidelines and care systems will be needed as innovative treatments gain evidence.
Australia's Therapeutic Goods Administration rescheduled MDMA in July 2023, permitting authorized prescribing for PTSD outside clinical trials. This manuscript describes development of an Australian Clinical Practice Guideline on MDMA-assisted psychotherapy for PTSD using the GRADE process. The guideline will compare benefits and harms of MDMA-assisted psychotherapy against other treatments, drawing on high-quality systematic reviews. A multidisciplinary Guideline Development Group will consider evidence certainty, patient values, resources, equity, acceptability, and feasibility. The guideline will be published on MAGICapp and disseminated through peer-reviewed publications and conferences. A Companion Guide will be created for people with PTSD and their carers.
Australia's Therapeutic Goods Administration rescheduled MDMA in July 2023, allowing its prescription for PTSD outside clinical trials. This manuscript outlines the development of an Australian Clinical Practice Guideline on MDMA-assisted psychotherapy for PTSD, using the GRADE process to weigh benefits and harms against other treatments. A multidisciplinary Guideline Development Group, supported by stakeholder and expert groups, will consider evidence certainty, patient values, resources, equity, acceptability, and feasibility. The guideline will be published on MAGICapp and in peer-reviewed outlets, with a companion guide for people with PTSD and their carers.